GOP Senators Distance Themselves From Grassley And Trump鈥檚 Efforts To Cut Drug Prices
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
Drugs
761 - 780 of 1,305 Results
-
-
KHN鈥檚 鈥榃hat The Health?鈥: Cue The Drug Price Debate
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this, plus court actions on health issues.
-
Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
-
A Conservative Group Paints Trump鈥檚 Drug-Pricing Experiment As 鈥楽ocialist.鈥 Is It?
The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president鈥檚 promise to curb high drug prices.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: Biden Doubles Down On Obamacare
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors鈥 鈥淢edicare for All鈥 plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN鈥檚 Julie Rovner to discuss this, plus Planned Parenthood鈥檚 very bad week, the U.S. House vote to repeal the health law鈥檚 鈥淐adillac tax鈥 on generous health plans, and the reduction in deaths from opioids.
-
KHN Investigation On Opioid Prescribers Pains Some Readers And Tweeters
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Common Medications Can Masquerade As Dementia In Seniors
A wide variety of medications used to treat allergies, insomnia, leaky bladders, diarrhea, dizziness, motion sickness, asthma, Parkinson鈥檚 disease, chronic obstructive pulmonary disease and psychiatric disorders can interfere with cognition in older patients.
-
Pain Meds As Public Nuisance? Oklahoma Tests A Legal Strategy Against Opioid Maker
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
-
A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant
Banking on new cost estimates, a bipartisan coalition in Congress is poised to try 鈥 once again 鈥 to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.
-
Even When HIV Prevention Drug Is Covered, Other Costs Block Treatment
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn鈥檛 apply to the other clinical and lab services people need.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: Could The ACA Really Go Away?
Is the entire Affordable Care Act unconstitutional? That was the question before a federal appeals court in New Orleans this week. Two of the three judges on the panel seemed inclined to agree with a lower court that the elimination of the tax penalty for failure to maintain coverage could mean the entire health law should fall. Also this week, President Donald Trump wants to improve care for people with kidney disease. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this, plus courts blocking efforts to require drug prices in TV ads and to kick Planned Parenthood out of the federal family planning program. Plus, Rovner interviews University of Michigan law professor Nicholas Bagley about the latest legal threat to the ACA.
-
How To Get A Cheaper Prescription Before Leaving The Doctor鈥檚 Office
A pricing tool embedded in their electronic health record and prescribing system lets doctors see how much patients will pay out-of-pocket based on their insurance and the pharmacy. But doctors have been slow to adopt the technology, which has limitations.
-
Watch: High Cost Of Insulin Sends Americans To Canada To Stock Up
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin 鈥 and the trend's deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
By Sarah Varney -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
-
Trump Has Blessed States鈥 Exploration Of Importing Drugs. Will It Catch On?
Colorado, Florida and Vermont 鈥 with the support of President Donald Trump 鈥 are exploring plans to bring drugs across the border from Canada to help lower costs.
-
KHN鈥檚 鈥榃hat The Health?鈥: Dems Debate Health Care
Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address 鈥渟urprise鈥 medical bills. Plus, Rovner interviews NPR鈥檚 Jon Hamilton about the latest KHN-NPR 鈥淏ill of the Month鈥 installment.
-
How Black Pharmacists Are Closing The Cultural Gap In Health Care
Independent black-owned pharmacies fill a void for African American patients looking for care that鈥檚 sensitive to their heritage, beliefs and values.
By Cara Anthony